PHIANH NGUYEN: Open Payments
NPI 1104254986 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 155 payments from 18 companies in 2025. Trend: 2023 $2,266 · 2024 $3,227 · 2025 $3,441
Food & beverage: $3,441
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $929 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $435 |
| Phathom Pharmaceuticals, Inc. | 8 | $275 |
| Ardelyx, Inc. | 15 | $263 |
| Janssen Biotech, Inc. | 7 | $227 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $224 |
| Madrigal Pharmaceuticals | 7 | $191 |
| Aimmune Therapeutics, Inc. | 11 | $166 |
| QOL Medical, LLC | 8 | $153 |
| PFIZER INC. | 7 | $131 |
Products named: RINVOQ, ENTYVIO, VOQUEZNA, IBSRELA, TREMFYA, DUPIXENT, XIFAXAN, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
